Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 11—November 2008
Dispatch

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005

Marya D. ZilberbergComments to Author , Andrew F. Shorr, and Marin H. Kollef
Author affiliations: EviMed Research Group, LLC, Goshen, Massachussetts, USA (M.D. Zilberberg); University of Massachusetts, Amherst, Massachusetts, USA (M.D. Zilberberg); Washington Hospital Center, Washington, DC, USA (A.F. Shorr)Barnes Jewish Hospital, St. Louis, Missouri, USA (M.H. Kollef);

Main Article

Figure

Population incidence of component resistant infections in the United States, by census region, 2000–2005. A) Clostridium difficile–associated disease; B) methicillin-resistant Staphylococcus aureus; C) vancomycin-resistant enterococcus; D) Pseudomonas aeruginosa; E) Candida spp.

Figure. Population incidence of component resistant infections in the United States, by census region, 2000–2005. A) Clostridium difficile–associated disease; B) methicillin-resistant Staphylococcus aureus; C) vancomycin-resistant enterococcus; D) Pseudomonas aeruginosa; E) Candida spp.

Main Article

Page created: July 18, 2010
Page updated: July 18, 2010
Page reviewed: July 18, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external